Cargando…
Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734828/ https://www.ncbi.nlm.nih.gov/pubmed/34657156 http://dx.doi.org/10.1182/blood.2021013429 |
| _version_ | 1784628095440912384 |
|---|---|
| author | Enßle, Julius C. Campe, Julia Schwenger, Amelie Wiercinska, Eliza Hellstern, Helen Dürrwald, Ralf Rieger, Michael A. Wolf, Sebastian Ballo, Olivier Steffen, Björn Serve, Hubert Bonig, Halvard Rabenau, Holger F. Widera, Marek Ciesek, Sandra Metzler, Ivana von Ullrich, Evelyn |
| author_facet | Enßle, Julius C. Campe, Julia Schwenger, Amelie Wiercinska, Eliza Hellstern, Helen Dürrwald, Ralf Rieger, Michael A. Wolf, Sebastian Ballo, Olivier Steffen, Björn Serve, Hubert Bonig, Halvard Rabenau, Holger F. Widera, Marek Ciesek, Sandra Metzler, Ivana von Ullrich, Evelyn |
| author_sort | Enßle, Julius C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8734828 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87348282022-01-07 Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma Enßle, Julius C. Campe, Julia Schwenger, Amelie Wiercinska, Eliza Hellstern, Helen Dürrwald, Ralf Rieger, Michael A. Wolf, Sebastian Ballo, Olivier Steffen, Björn Serve, Hubert Bonig, Halvard Rabenau, Holger F. Widera, Marek Ciesek, Sandra Metzler, Ivana von Ullrich, Evelyn Blood Letters to Blood American Society of Hematology. 2022-01-06 2021-10-19 /pmc/articles/PMC8734828/ /pubmed/34657156 http://dx.doi.org/10.1182/blood.2021013429 Text en Copyright © 2022 American Society of Hematology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letters to Blood Enßle, Julius C. Campe, Julia Schwenger, Amelie Wiercinska, Eliza Hellstern, Helen Dürrwald, Ralf Rieger, Michael A. Wolf, Sebastian Ballo, Olivier Steffen, Björn Serve, Hubert Bonig, Halvard Rabenau, Holger F. Widera, Marek Ciesek, Sandra Metzler, Ivana von Ullrich, Evelyn Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma |
| title | Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma |
| title_full | Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma |
| title_fullStr | Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma |
| title_full_unstemmed | Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma |
| title_short | Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma |
| title_sort | severe impairment of t-cell responses to bnt162b2 immunization in patients with multiple myeloma |
| topic | Letters to Blood |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734828/ https://www.ncbi.nlm.nih.gov/pubmed/34657156 http://dx.doi.org/10.1182/blood.2021013429 |
| work_keys_str_mv | AT enßlejuliusc severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT campejulia severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT schwengeramelie severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT wiercinskaeliza severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT hellsternhelen severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT durrwaldralf severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT riegermichaela severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT wolfsebastian severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT balloolivier severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT steffenbjorn severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT servehubert severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT bonighalvard severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT rabenauholgerf severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT wideramarek severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT cieseksandra severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT metzlerivanavon severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma AT ullrichevelyn severeimpairmentoftcellresponsestobnt162b2immunizationinpatientswithmultiplemyeloma |